What's breaking now, across thousands of outlets.
A patient and community oncologist share how trust, partnership and shared decision-making shaped a CAR-T journey in multiple myeloma.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.
‘Hunterase’, a treatment for Hunter syndrome developed by GC Biopharma, has successively obtained product approval in major Asian countries India and Taiwan.GC Biopharma announced on August 24 that it…
Case fatality rate climbs to nearly 48 percent in DRC, meaning almost one in two people infected with Ebola are dying.
A PERSONALISED mRNA-based cancer vaccine developed by Moderna and Merck & Co. has delivered a landmark result in a late-stage melanoma trial, strengthening hopes that technology originally propelled…
Pope Leo called on Sunday for international action to help contain the impact of an Ebola outbreak in the Democratic Republic of Congo, which has so far claimed more than 2,500 lives.
Sexual violence persists as stakeholders demand tougher action against perpetrators.
